MillerMG, CornerJ. The 'n = 1' randomized controlled trial. Palliat Med, 1999; 13:255–259.
5.
ZuckerDR, SchmidCH, McIntoshMW, D'AgostinoRB, SelkerHP, LauJ. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual participant responses to treatment. J Clin Epidemiol, 1997; 50:401–410.
6.
SchluterPJ, WareRS. Single patient (n-of-1) trials with binary treatment preference. Stat Med, 2005; 24:2625–2636.
7.
GuyattGH, HaynesRB, JaeschkeRZ, CookDJ, GreenL, NaylorCD, WilsonMC, RichardsonWS. Users' guides to the medical literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA, 2000; 284:1290–1296.
8.
BrueraE, SchoellerT, MacEachernT. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: The use of the N of 1 randomized controlled trial. J Pain Symptom Manage, 1992; 7:365–368.
9.
NiklesJ, MitchellG, WaltersJ, HardyJ, GoodP, RowettD, Shelby-JamesT, CurrowD. Prioritising palliative care medicines for single patient trials. Palliat Med, 2009; 23:623–634.
10.
MitchellG, HardyJ, CarmontS, O'SheaA, VoraR, SchluterP, NiklesC. Pilot Study to dose of determine the optimal methylphenidate for an n-of-1 trial for fatigue in cancer patients. J Palliat Med, 2010; 13:1193–1197.